About Castle Creek Biosciences
Castle Creek Biosciences is a company based in Exton (United States) founded in 2018.. Castle Creek Biosciences has raised $192.8 million across 4 funding rounds from investors including Fidelity Investments, Paragon Biosciences and Horizon Tech Finance. The company has 41 employees as of December 31, 2022. Castle Creek Biosciences operates in a competitive market with competitors including Ironwood Pharma, Amryt Pharma, Castle Creek Pharma, VeraDermics and Lipum, among others.
- Headquarter Exton, United States
- Employees 41 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Castle Creek Biosciences, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$192.8 M (USD)
in 4 rounds
-
Latest Funding Round
$112.8 M (USD), Series D
Jan 18, 2022
-
Investors
Fidelity Investments
& 3 more
-
Employee Count
41
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Castle Creek Biosciences
Castle Creek Biosciences has successfully raised a total of $192.8M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $112.8 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series D — $112.8M
-
First Round
First Round
(25 Mar 2020)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2022 | Amount | Series D - Castle Creek Biosciences | Valuation | Fidelity Investments , Valor Equity Partners |
|
| Jun, 2021 | Amount | Series C - Castle Creek Biosciences | Valuation |
investors |
|
| Mar, 2020 | Amount | Series C - Castle Creek Biosciences | Valuation | Paragon Biosciences |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Castle Creek Biosciences
Castle Creek Biosciences has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, Paragon Biosciences and Horizon Tech Finance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm
|
Founded Year | Domain | Location | |
|
Structured debt is provided to life sciences and technology firms.
|
Founded Year | Domain | Location | |
|
Provider of brokerage accounts, retirement planning, wealth management, and trading platforms
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Castle Creek Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Castle Creek Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Castle Creek Biosciences Comparisons
Competitors of Castle Creek Biosciences
Castle Creek Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ironwood Pharma, Amryt Pharma, Castle Creek Pharma, VeraDermics and Lipum, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare dermatological and orphan diseases are developed.
|
|
| domain | founded_year | HQ Location |
Drugs for skin diseases, ENT disorders, and rare diseases such as urea cycle disorders
|
|
| domain | founded_year | HQ Location |
Drug-delivery platforms for pediatric wart treatments are developed.
|
|
| domain | founded_year | HQ Location |
Developer of antibody to treat juvenile idiopathic arthritis
|
|
| domain | founded_year | HQ Location |
Medicines for chronic diseases in children are developed and provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Castle Creek Biosciences
Frequently Asked Questions about Castle Creek Biosciences
When was Castle Creek Biosciences founded?
Castle Creek Biosciences was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is Castle Creek Biosciences located?
Castle Creek Biosciences is headquartered in Exton, United States. It is registered at Exton, Pennsylvania, United States.
Is Castle Creek Biosciences a funded company?
Castle Creek Biosciences is a funded company, having raised a total of $192.8M across 4 funding rounds to date. The company's 1st funding round was a Series C of $55M, raised on Mar 25, 2020.
How many employees does Castle Creek Biosciences have?
As of Dec 31, 2022, the latest employee count at Castle Creek Biosciences is 41.
What does Castle Creek Biosciences do?
Castle Creek Biosciences was founded in 2018 and is headquartered in Exton, United States. A gene therapy platform based on autologous fibroblasts derived from patient skin cells is offered for rare skin and connective tissue disorders, including epidermolysis bullosa and localized scleroderma. Clinical development includes FCX-007 in phase 3 trials, with FCX-013 and CCP-020 in phase 2. Operations focus on dermatology and related rare disease areas.
Who are the top competitors of Castle Creek Biosciences?
Castle Creek Biosciences's top competitors include Ironwood Pharma, VeraDermics and Amryt Pharma.
Who are Castle Creek Biosciences's investors?
Castle Creek Biosciences has 4 investors. Key investors include Fidelity Investments, Paragon Biosciences, Horizon Tech Finance, and Valor Equity Partners.